Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 22393134)

1.

Screening for liver cancer: the rush to judgment.

Lederle FA, Pocha C.

Ann Intern Med. 2012 Mar 6;156(5):387-9. doi: 10.7326/0003-4819-156-5-201203060-00012.

PMID:
22393134
2.

Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B.

Aghoram R, Cai P, Dickinson JA.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD002799. doi: 10.1002/14651858.CD002799.pub2. Review.

PMID:
22972059
3.

Screening for liver cancer: the rush to judgment.

Sherman M, Bruix J.

Ann Intern Med. 2012 Aug 21;157(4):300-1; author reply 301-2. doi: 10.7326/0003-4819-157-4-201208210-00021. No abstract available.

PMID:
22910949
4.
5.

Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.

Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, Huang GT, Yang PM, Lee HS, Duffy SW.

Int J Cancer. 2002 Mar 10;98(2):257-61.

PMID:
11857416
6.

Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?

Poustchi H, Farrell GC, Strasser SI, Lee AU, McCaughan GW, George J.

Hepatology. 2011 Dec;54(6):1998-2004. doi: 10.1002/hep.24581.

PMID:
21800340
7.

High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.

Fasani P, Sangiovanni A, De Fazio C, Borzio M, Bruno S, Ronchi G, Del Ninno E, Colombo M.

Hepatology. 1999 Jun;29(6):1704-7.

PMID:
10347111
8.

An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.

Mok TS, Yeo W, Yu S, Lai P, Chan HL, Chan AT, Lau JW, Wong H, Leung N, Hui EP, Sung J, Koh J, Mo F, Zee B, Johnson PJ.

J Clin Oncol. 2005 Nov 1;23(31):8041-7.

9.

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.

Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, Jackson S, Ryder S, Price A, Stein K.

Health Technol Assess. 2007 Sep;11(34):1-206. Review.

10.

Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities.

Trinchet JC, Chaffaut C, Bourcier V, Degos F, Henrion J, Fontaine H, Roulot D, Mallat A, Hillaire S, Cales P, Ollivier I, Vinel JP, Mathurin P, Bronowicki JP, Vilgrain V, N'Kontchou G, Beaugrand M, Chevret S; Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire (GRETCH).

Hepatology. 2011 Dec;54(6):1987-97. doi: 10.1002/hep.24545.

PMID:
22144108
11.

Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.

Daniele B, Bencivenga A, Megna AS, Tinessa V.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S108-12. Review.

PMID:
15508073
12.

Randomized controlled trial of screening for hepatocellular carcinoma.

Zhang BH, Yang BH, Tang ZY.

J Cancer Res Clin Oncol. 2004 Jul;130(7):417-22.

PMID:
15042359
13.

Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.

Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB.

Am J Gastroenterol. 2003 Mar;98(3):679-90.

PMID:
12650806
14.

Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.

Huang YC, Huang CF, Chang KC, Hung SF, Wang JH, Hung CH, Chen CH, Tseng PL, Kee KM, Yen YH, Tsai PS, Tsai CC, Lu SN.

J Gastroenterol Hepatol. 2011 Jan;26(1):129-34. doi: 10.1111/j.1440-1746.2010.06476.x.

PMID:
21175806
15.

Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.

Larcos G, Sorokopud H, Berry G, Farrell GC.

AJR Am J Roentgenol. 1998 Aug;171(2):433-5.

PMID:
9694470
16.

Irregularity of parenchymal echo patterns of liver analyzed with a neural network and risk of hepatocellular carcinoma in liver cirrhosis.

Fukuda H, Ebara M, Kobayashi A, Sugiura N, Yoshikawa M, Saisho H, Kato K, Kondo F, Yahagi T.

Oncology. 2002;63(3):270-9.

PMID:
12381907
17.

Efficacy of a surveillance program for early detection of hepatocellular carcinoma.

Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E.

Cancer. 1996 Sep 1;78(5):977-85.

PMID:
8780534
18.

Factors associated with use of ultrasonography screening for hepatocellular carcinoma among hepatitis B or C carriers.

Cho ER, Shin A, Choi KS, Lee HY, Kim J.

Cancer Epidemiol. 2010 Dec;34(6):713-6. doi: 10.1016/j.canep.2010.09.003. Epub 2010 Oct 13.

PMID:
20947465
19.

[Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin].

Henrion J, Libon E, De Maeght S, Deltenre P, Schapira M, Ghilain JM, Maisin JM, Heller FR.

Gastroenterol Clin Biol. 2003 May;27(5):534-9. French.

20.

Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosis.

Okano H, Shiraki K, Inoue H, Ito T, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Nakano T.

Anticancer Res. 2001 Jul-Aug;21(4B):2979-82.

PMID:
11712797
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk